Related Experiment Video
Updated: Jul 6, 2026

Inducing Acute Liver Injury in Rats via Carbon Tetrachloride (CCl4) Exposure Through an Orogastric Tube
Published on: April 28, 2020
Critical role of CD44 in hepatotoxin-mediated liver injury
Kiminori Kimura1, Masahito Nagaki, Kazuhiro Kakimi
1Department of Immunotherapeutics (Medinet), Graduate School of Medicine, The University of Tokyo, 1-3-7 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan. kkimura@m.u-tokyo.ac.jp
Background/Aims:
Blocking of adhesion molecules is considered to be one of the therapeutic strategies inflammatory diseases, although it remains unclear whether this strategy is beneficial.
Methods:
We used CD44-deficient mice to assess whether inhibition of CD44 could control liver injury caused by carbon tetrachloride (CCl(4)).
Results:
CD44-deficient mice exhibited suppressed liver inflammation during the early phase (within 6h) after CCl(4) injection due to reduced inflammatory cell infiltration and cytokine production, but showed severe liver inflammation with increased numbers of apoptotic hepatocytes at the late phase (after 12h). The induction of hepatocyte apoptosis was triggered by reduced NF-kappaB activity, which was induced by the low inflammatory cytokine concentrations. Furthermore, macrophages contributed to the induction of hepatocyte apoptosis, since neutralization by an anti-CD11b antibody significantly protected against hepatocyte apoptosis. Finally, we found that blocking of MIP-2 and TNF-alpha reduced hepatocyte apoptosis with decreased numbers of intrahepatic leukocytes and reduced inflammatory cytokine production.
Conclusions:
These findings suggest that targeting of CD44 as a therapeutic approach for inflammatory liver diseases may require caution for particular immune systems in the liver.
Insights
Targeting CD44 in inflammatory liver diseases shows mixed results. While it suppresses early inflammation, it can worsen liver injury later by increasing hepatocyte apoptosis, suggesting caution is needed.
Area of Science:
- Immunology
- Hepatology
- Pharmacology
Background:
- Blocking adhesion molecules is a potential therapeutic strategy for inflammatory diseases.
- The efficacy of targeting adhesion molecules like CD44 in liver inflammation remains unclear.
Purpose of the Study:
- To investigate the role of CD44 in controlling liver injury induced by carbon tetrachloride (CCl4).
- To assess the therapeutic potential of CD44 inhibition in inflammatory liver conditions.
Main Methods:
- Utilized CD44-deficient mice to model CCl4-induced liver injury.
- Analyzed inflammatory cell infiltration, cytokine production, and hepatocyte apoptosis.
- Investigated the involvement of NF-kappaB, macrophages, MIP-2, and TNF-alpha.
Main Results:
- CD44 deficiency initially suppressed liver inflammation and cytokine production within 6 hours post-CCl4 injection.
- However, CD44 deficiency led to severe liver inflammation and increased hepatocyte apoptosis after 12 hours.
- Hepatocyte apoptosis was linked to reduced NF-kappaB activity and macrophage involvement, with MIP-2 and TNF-alpha playing a role.
Conclusions:
- Targeting CD44 for inflammatory liver diseases requires careful consideration of the liver's immune system.
- The dual role of CD44 in early suppression and late exacerbation of liver injury necessitates cautious therapeutic application.
Related Concept Videos
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Cirrhosis II: Pathophysiology
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Hepatitis
Hepatic Encephalopathy
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

